Did National Security Imperatives Compromise COVID-19 Vaccine Safety?

Did National Security Imperatives Compromise COVID-19 Vaccine Safety? 

In addition to Phillip M. Altman BPharm(Hons) MSc PhD, coauthors on this piece include James Rowe BPharm, MSc, PhD FRSN, Wendy Hoy AO FAA FRACP, Gerry Brady  MBBS, Astrid Lefringhausen, PhD, Robyn Cosford MBBS(Hons) FACNEM FASLM, and Bruce Wauchope MBBS – DTM&H, Dip OBS RACOG, FRACGP.

The US Department of Defense (US DoD) has had a dominant role in the response to the SARS-CoV-2 virus and in the development, and distribution of the Covid 19 vaccines, a fact hidden from the general public. In those processes many standard steps and procedures, otherwise required for pharmaceutical products, were omitted or circumvented.  

Definition of these vaccines as “countermeasures” rather than therapeutic agents has permitted their expedited progression to emergency use authorisation and widespread rollouts. Many adverse consequences have been the outcome of this secret military response to a public health matter. Why are governments around the world, including Australia, planning to make further significant investments in this rushed vaccine technology driven by the US military?

Operation Warp Speed

With the US Food and Drug Administration’s Emergency Use Authorisation of the COVID-19 vaccines (FDA, 2020) and the Provisional Approval of the first COVID-19 vaccine in Australia (TGA, 2021), these agents were hailed as innovative life-saving responses by the pharmaceutical industry to a deadly global pandemic.  

GO READ THE WHOLE THING.